Table 1. Lysosomal storage disorders.
Disease | Defective protein | Major storage materials |
---|---|---|
Sphingolipidoses |
|
|
Gaucher disease |
GBA/acid β-glucosidase |
Glucosylceramide |
Fabry disease |
GLA/α-galactosidase A |
Globotriaosylceramide |
GM1 gangliosidosis |
GLB1/β-galactosidase |
GM1 ganglioside |
Niemann-Pick type C disease |
NPC1 or NPC2 |
Cholesterol and sphingolipids |
Mucopolysaccharidoses (MPS) |
|
|
MPS IIIA (Sanfilippo syndrome) |
SGSH/N-sulfoglucosamine sulfohydrolase |
Heparan sulfate |
MPS VI (Maroteaux–Lamy syndrome) |
ARSB/arylsulfatase B |
Dermatan sulfate |
Multiple sulfatase deficiency |
SUMF1/sulfatase modifying factor 1 |
Sulfatide and glycosaminoglycans |
Mucolipidoses (ML) |
|
|
ML II (I-cell disease) |
GNPTAB/N-acetylglucosamine-1-phosphate transferase |
Glycosaminoglycans and lipids |
ML III |
GNPTAB/N-acetylglucosamine-1-phosphate transferase |
Glycosaminoglycans and lipids |
ML IV |
MCOLN1/mucolipin 1 |
Glycosaminoglycans and lipids |
Glycogen storage disease |
|
|
Pompe disease (glycogen storage disease type II) |
GAA/acid α-glucosidase |
Glycogen |
Danon disease |
LAMP2 |
Glycogen and cytoplasmic debris |
Neuronal ceroid lipofuscinoses (CLN) |
|
|
Batten disease (JNCL) |
CLN3/battenin |
Subunit c of mitochondrial ATP synthase |
CLN 10 | CTSD/cathepsin D | Granular osmiophilic deposits |
This table shows examples of lysosomal storage diseases that are accompanied by accumulation of autophagic vesicles.